Ferroptosis mediators vary in metabolic syndrome,type-2 diabetes,and hypercholesterolemia:A meta-analysis report  

作　　者：Indra Kundu Ashlesha Pande Tannishtha Das Susan Idicula-Thomas 

机构地区：[1]Biomedical Informatics Centre,Indian Council of Medical Research-National Institute for Research in Reproductive and Child Health,Mumbai,Maharashtra 400012,India [2]Department of Biotechnology,St.Xavier's College,Kolkata,West Bengal 700016,India

出　　处：《Genes & Diseases》2024年第3期109-112,共4页基因与疾病（英文）

基　　金：This work(RA/1346/11-2022)was supported by grants received from the Department of Biotechnology,Ministry of Science and Technology;Government of India(BT/PR40165/BTIS/137/12/2021);Science and Engineering Research Board(India)(STR/2020/000034);the Indian Council of Medical Research,India(BMI/11(51)/2022).

摘　　要：Metabolic syndrome(MetS)is a complex disorder characterized by the coexistence of phenotypes such as obesity,hypertension,hyperglycemia,high triglyceride level,and low level of high-density lipoprotein cholesterol.Inflammation majorly driven by oxidative stress has an overarching role in obesity and IR-mediated mechanisms leading to Mets.Besides these factors.

关 键 词：OBESITY CHOLESTEROL DIABETES 

分 类 号：R587.1[医药卫生—内分泌] R589[医药卫生—内科学]